Trial intelligence / Profile preview

Intravenous propofol versus ketorolac for analgesia in renal colic

IRCT20180124038488N1Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of propofol and ketorolac in Lithiasis and Renal colic (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Analgesic effect of propofol in patients with renal colic. Started Feb 2018; status: completed.

02

Drugs

propofolketorolac
03

Conditions

LithiasisRenal colic

Beyond the preview

Go deeper on IRCT20180124038488N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180124038488N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call